Parkinson’s Approach With Stem Cells A Promising First Step
Brain cells derived from human embryonic stem cells improved the condition of rats with Parkinson’s-like symptoms dramatically, but the treatment caused a significant problem – the appearance of brain tumors – that scientists are now working to solve.
HIV Gene Therapy ‘Ferry’ in Works
Scientists in New York are working to transform HIV into a gene therapy vector so that corrective DNA can be incorporated into patients’ chromosomes to help treat diseases such as thalassemia and sickle cell disease.
Molecular ‘Marker’ on Stem Cells Aids Research, Perhaps Therapies
A sugar molecule present on embryonic stem cells also has been found on the surface of a type of adult stem cell, a discovery that may help researchers isolate and purify adult stem cells for use in therapies aimed at bone healing, tendon repair and cartilage regeneration, researchers at UT Southwestern Medical Center report.
Apollo Life Science’s Human Proteins Lead to Improved Cancer Treatment by Boosting Stem Cell Growth
Initial studies show human proteins outperform competitor proteins in stimulating faster growth in numbers of blood-producing stem cells
siRNAs Can Slow Spread of Prion-based BSE, CJD
German scientists used special RNAs to halt the production of proteins loosened by prion disease similar to BSE and its human version, Creutzfeldt-Jakob disease, a new study says.
ReNeuron Announces Filing IND Application to the FDA for ReN001
ReNeuron Group plc today announces the filing of its first Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to commence initial clinical studies in the US with ReN001, its stem cell therapy for stroke.
Provenge(R), Activated Cellular Immunotherapy, Shows Promise for Treatment of Androgen Independent Prostate Cancer
Researchers involved in a multicenter trial have reported that Provenge(R) (Sipuleucel-T) may improve the survival of patients with asymptomatic metastatic androgen independent prostate cancer (AIPC) when compared to patients receiving a placebo.
Oxford BioMedica’s Trovax(R) Receives Positive Recommendation
Oxford BioMedica, a leading gene therapy company, has announced that it has received positive opinion from the Committee for Orphan Medicinal Products (COMP) recommending orphan drug designation for TroVax for the treatment of patients with renal cancer in the European Union (EU).
Stem Cell Therapy Moves from Theory to Reality
Despite setbacks and controversy, promising research is underway.
Experts Propose New Convention for Human Embryonic Stem Cell Derivation
Experts have today proposed a new convention for the reporting on the derivation of human embryonic stem cell (hESC) lines.
ABSTRACT, REVIEWS AND SPECIAL REPORTS
Proposal for a Universal Minimum Information Convention for the Reporting on the Derivation of Human Embryonic Stem Cell Lines
The implementation of novel methodology across the human embryonic stem cell (hESC) field is fraught with difficulties, not least of which is the highly variable reporting of the number and quality of embryos used to derive each new hESC line. In this editorial, the authors highlight the variation in data published and voice suggestions as to how the reporting can become standardized and so facilitate progress in human embryonic stem cell derivation.